Phase III Lot Consistency, Immunogenicity and Safety Study of Three Lots of Fluzone High Dose Vaccine Compared With One Lot of Standard Fluzone in Adults =65 Years of Age.
Phase of Trial: Phase III
Latest Information Update: 04 Apr 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Registrational
- Sponsors sanofi pasteur
- 25 Aug 2009 Actual patient number changed from 3837 to 3876 as reported by ClinicalTrials.gov.
- 15 Jul 2009 Results published in the Journal of Infectious Diseases.
- 26 Oct 2008 Results have been reported at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th annual meeting, according to a Sanofi Pasteur media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History